SAE2/UBA2 Antibody

About the Target

SAE2 (also known as UBA2) is a key component of the SUMO (Small Ubiquitin-like Modifier) conjugation pathway, functioning as the E1 SUMO-activating enzyme. It forms a complex with SAE1 to activate SUMO proteins by forming a thioester bond with the SUMO's C-terminal glycine. The activation of SUMO by SAE2/UBA2 is an essential first step in the SUMOylation process, enabling SUMO to be transferred to target proteins through the action of the E2 enzyme Ubc9. Depending on the literature source, SAE2/UBA2 may also be discussed as SAE2/UBA2 and UBLE1B.

Reported cellular context includes cytoplasm and nucleus, which can matter when signal is compared across treatments or changing cell states. Following SAE2/UBA2 across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

SAE2/UBA2 is commonly interpreted in the context of cancer, stem cell biology, and cell cycle research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm and nucleus, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm and nucleus across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• state transitions between self-renewal, priming, and differentiation
• cell-cycle linked differences in abundance, timing, or compartmental enrichment

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for SAE2/UBA2. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in SAE2/UBA2 reflect biology rather than handling. When interpreting SAE2/UBA2, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep SAE2/UBA2 trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.